Ddavp

   
Google
 
Web NewDrugInformation.com

Ddavp


Drug - Ddavp
The trade name of the product as shown on the labeling.

Dosage - TABLET; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Desmopressin Acetate
Multiple ingredients are in alphabetical order.

Strength - 0.1MG
The potency of the active ingredient(s), Desmopressin Acetate. May repeat for multiple part products.

Applicant - AVENTIS
The firm name holding legal responsibility for Ddavp. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 019955
The FDA assigned number to Ddavp. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Ddavp. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code - AB
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Sep 6, 1995
The date Ddavp was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Ddavp. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Ddavp is in. Format is RX, OTC, DISCN.

Applicant Full Name - Aventis Pharmaceutical Products Inc
The full name of the firm holding legal responsibility for the new application of Ddavp.

Ddavp